Kava's days might be numbered

January 2002

Kava's days might be numbered...due to possible hepatotoxicity.

We alerted you last March about reports of acute hepatitis.

Now there are at least 30 cases in Europe of hepatic failure, hepatitis, and cirrhosis...including a death and 3 liver transplants.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Statin Comparison Chart--New generics for lovastatin (Mevacor) will hit the market
new COX-2 inhibitor called Bextra (valdecoxib)
Neurology & Pain Percocet now comes in two new strengths
Migraine how to pick a triptan
warning about possible hepatic failure with Serzone
Focalin, a new stimulant for attention deficit hyperactivity disorder (ADHD)
Infectious Diseases teenagers and adults with persistent cough actually have pertussis (whooping cough)
Infectious Diseases new injectable antibiotic called Invanz (IN-vance, ertapenem)
fluoxetine (Prozac, etc) is beneficial for some patients with Raynaud's phenomenon
Sepsis Xigris (Zy-gris, drotrecogin alfa), a new biotech drug for treating severe sepsis
Sepsis controlling hyperglycemia with insulin reduces sepsis in critically ill patients
Cardiology Antioxidants are out, now B vitamins are in for heart disease
Cardiology stronger warnings about serious arrhythmias when using droperidol (Inapsine)
Vaccines whether it's safe for warfarin patients to get influenza or pneumococcal vaccines
Vaccines Not enough adults with asthma are getting the flu vaccine
Supplements Kava's days might be numbered
Practice annual new drug chart for 2001
Practice annual new drug chart for 2001
Practice annual new drug chart for 2001
Practice annual new drug chart for 2001